Status:
COMPLETED
Prospective Assessment of Symptoms and Quality of Life in Rectal Cancer Patients Receiving Chemo-Radiotherapy
Lead Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Collaborating Sponsors:
University of Michigan
Conditions:
Rectal Cancer
Eligibility:
All Genders
18-100 years
Brief Summary
Prospective Assessment of Symptoms and Quality of Life in Rectal Cancer Patients Receiving Chemo-Radiotherapy.
Detailed Description
STUDY PLAN 1. Only the principal investigator, sub-investigators, and research nurse will be approaching potential participants. The above listed also will be the only consentors for the study. The r...
Eligibility Criteria
Inclusion
- All of the following questions must be answered "yes" for a patient to be eligible for this protocol.
- Is there a working diagnosis of rectal cancer? YES NO
- Will the patient be receiving neoadjuvant concurrent chemotherapy and pelvic radiation? YES NO
- Is the pelvic radiation planned for a dose of 45-54 Gy and will it be delivered using a standard 3-field technique? YES NO
- Is the patient ≥ 18 years of age? YES NO
- Can the patient give informed consent? YES NO
Exclusion
- All of the following questions must be answered "no" for a patient to be eligible for this protocol.
- Has there been prior radiation to the pelvis? YES NO
- Is the patient in the "special category" designated by the Public Health Service (patients younger than 18, pregnant women, and prisoners)? YES NO
Key Trial Info
Start Date :
November 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2010
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT00414232
Start Date
November 1 2006
End Date
October 1 2010
Last Update
November 26 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Sidney Kimmel Comprehensive Cancer Center at The Johns Hopkins University
Baltimore, Maryland, United States, 21231